Neuronetics, Inc. (STIM)
1.52
+0.03
(+2.01%)
USD |
NASDAQ |
Apr 02, 16:00
1.54
+0.02
(+1.32%)
After-Hours: 20:00
Neuronetics Shareholders Equity (Quarterly) : 22.38M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| InspireMD, Inc. | 55.20M |
| Tactile Systems Technology, Inc. | 218.90M |
| Celldex Therapeutics, Inc. | 527.16M |
| Plus Therapeutics, Inc. | 3.996M |
| Atossa Therapeutics, Inc. | 39.35M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 141.55M |
| Total Liabilities (Quarterly) | 115.31M |
| Debt to Equity Ratio | 4.035 |
| Current Ratio | 2.017 |
| Net Debt Paydown Yield | -8.74% |